Arkachaisri Thaschawee, Teh Kai Liang, Book Yun Xin, Hoh Sook Fun, Gao Xiaocong, Das Lena
Rheumatology and Immunology Service, Department of Pediatric Subspecialties, KK Women's and Children's Hospital, Singapore 229899, Singapore.
Duke-NUS Medical School, Pediatric Academic Clinical Program, Singapore 169857, Singapore.
J Clin Med. 2021 Feb 3;10(4):568. doi: 10.3390/jcm10040568.
. To describe the clinical characteristics, predictors and treatment of children with Enthesitis Related Arthritis (ERA) in a Singapore longitudinal cohort over 11 years. . ERA patients were recruited from our registry (2009-2019). Nonparametric descriptive statistics including median (interquartile range, IQR) were used to describe data. Kaplan-Meier survival and logistic/Cox regression analyses were used to estimate the probabilities and determine predictors of clinical variables, respectively. The significance level was set at <0.05. . One hundred and forty-six ERA patients (87% male, 82% Chinese) were included. Median onset age was 11.9 years (IQR 9.4-14.0) and median disease duration was 4.9 years (IQR 2.6-8.3). Family history of Human Leukocyte Antigen (HLA)-B27 associated diseases was positive in 7.5%. Acute uveitis occurred in 3.4%. Oligoarthritis was present in 89.7%. Hip, knee and ankle joints were among the most common joints involved. One-fourth had enthesitis at diagnosis (Achilles tendon entheses, 82.9%). Sacroiliitis occurred in 61%. Probabilities of sacroiliitis development were 0.364, 0.448 and 0.578 at 1, 2 and 5 years after onset, respectively. Negative HLA-B27, female, older age at onset and hip arthritis at diagnosis were associated with shorter time for sacroiliitis development ( = 0.001-0.049). Methotrexate (MTX) remained the most common disease modifying anti-rheumatic drug (DMARD) used (77.4%). However, 77.9% required anti-TNF (aTNF) therapy secondary to MTX failure. Among MTX-treated sacroiliitis patients, 85.3% failed, requiring aTNF, as compared to 63.2%patients without axial disease. Longer duration to diagnosis ( = 0.038) and MTX use ( = 0.007) predicted aTNF therapy. None had joint deformity. . This study underscores differences in ERA clinical characteristics, predictors and treatment responses. Our ERA population had many unique findings but good functional outcomes.
描述新加坡一个为期11年的纵向队列中附着点炎相关关节炎(ERA)患儿的临床特征、预测因素及治疗情况。ERA患者从我们的登记处招募(2009 - 2019年)。使用包括中位数(四分位间距,IQR)在内的非参数描述性统计来描述数据。分别采用Kaplan - Meier生存分析和逻辑/ Cox回归分析来估计概率并确定临床变量的预测因素。显著性水平设定为<0.05。纳入146例ERA患者(87%为男性,82%为华裔)。发病年龄中位数为11.9岁(IQR 9.4 - 14.0),病程中位数为4.9年(IQR 2.6 - 8.3)。人类白细胞抗原(HLA)- B27相关疾病家族史阳性率为7.5%。急性葡萄膜炎发生率为3.4%。少关节炎发生率为89.7%。髋、膝和踝关节是最常受累的关节。四分之一的患者在诊断时有附着点炎(跟腱附着点,82.9%)。骶髂炎发生率为61%。发病后1年、2年和5年骶髂炎发展的概率分别为0.364、0.448和0.578。HLA - B27阴性、女性、发病年龄较大及诊断时患髋关节炎与骶髂炎发展时间较短相关(P = 0.001 - 0.049)。甲氨蝶呤(MTX)仍然是最常用的改善病情抗风湿药物(DMARD)(77.4%)。然而,77.9%的患者因MTX治疗失败需要抗TNF(aTNF)治疗。在接受MTX治疗的骶髂炎患者中,85.3%治疗失败,需要aTNF治疗,而无轴向疾病的患者这一比例为63.2%。诊断时间较长(P = 0.038)和使用MTX(P = 0.007)预示着需要aTNF治疗。无一例患者出现关节畸形。本研究强调了ERA临床特征、预测因素及治疗反应的差异。我们的ERA患者群体有许多独特的发现,但功能结局良好。